Novel artificial urinary sphincter Uromems raises $17.5M to advance development of its electronic artificial urinary sphincter June 4, 2020 By Bernard Banga PARIS – Uromems SAS, of Grenoble, France, reported the completion of a series B round of $17.5 million to advance development of its implantable mechatronic device for treating stress urinary incontinence.Read More
FDA approves VESIcare LS oral suspension for neurogenic detrusor overactivity in pediatric patients May 28, 2020
Cara reports topline data from KALM-2 trial of Korsuva in hemodialysis patients with pruritus April 21, 2020
RSS
